Top

Published in:

Open Access 01-09-2018 | Sleep Breathing Physiology and Disorders • Review

Kleine-Levin syndrome: clues to aetiology

Authors: Saad Mohammed AlShareef, Richard Mark Smith, Ahmed Salem BaHammam

Published in: Sleep and Breathing | Issue 3/2018

Abstract

Kleine-Levin syndrome (KLS) is the commonest recurrent sleep disorder, with a prevalence of 1–2 per million population. Clear diagnostic criteria are now defined, but effective treatment remains elusive. The significant body of published literature allows consideration of possible aetiological mechanisms, an understanding of which could guide the development of therapeutic strategies. Functional imaging studies have been inconclusive; although diencephalic abnormalities are a common finding, no consistent pattern has emerged, and these studies have not revealed the mechanism(s) underlying the development of the abnormalities detected. An autoimmune aetiology is consistent with the available data. In this review, we argue that, in order to further our understanding of KLS, there needs to be a co-ordinated international effort to standardise approaches to functional imaging studies, genetic analyses that specifically address the possibility of an autoimmune aetiology, and clinical trials of immunosuppressive therapies.

American Academy of Sleep Medicine. International Classification of Sleep Disorders - Third Edition (ICSD-3). (2014) Darien (IL): American Academy of Sleep Medicine

Dauvilliers Y, Mayer G, Lecendreux M, Neidhart E, Peraita-Adrados R, Sonka K, Billiard M, Tafti M (2002) Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses. Neurology 59(11):1739–45. https://doi.org/10.1212/01.WNL.0000036605.89977.D0

Arnulf I, Zeitzer JM, File J, Farber N, Mignot E (2005) Kleine–Levin syndrome: a systematic review of 186 cases in the literature. Brain 128(12):2763–76, https://doi.org/10.1093/brain/awh620

Arnulf I, Lin L, Gadoth N, File J, Lecendreux M, Franco P, Zeitzer J, Lo B, Faraco JH, Mignot E (2008) Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol 63(4):482–493. https://doi.org/10.1002/ana.21333 CrossRefPubMed

Arnulf I, Rico TJ, Mignot E (2012) Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol 11(10):918–928. https://doi.org/10.1016/S1474-4422(12)70187-4

Billiard M, Jaussent I, Dauvilliers Y, Besset A (2011) Recurrent hypersomnia: a review of 339 cases. Sleep Med Rev 15(4):247–57. https://doi.org/10.1016/j.smrv.2010.08.001

Billiard M, Peraita-Adrados R, Tafti M (2013) Genetics of recurrent hypersomnia. In: Shaw P, Tafti M, Thorpy M (eds) The genetic basis of sleep and sleep disorders. Cambridge University Press, Cambridge, pp 272–277. https://doi.org/10.1017/CBO9781139649469.029 CrossRef

Miglis MG, Guilleminault C (2014) Kleine-Levin syndrome: a review. Nat Sci Sleep 6:19–26. https://doi.org/10.2147/NSS.S44750 PubMedPubMedCentralCrossRef

Al Suwayri SM (2016) Kleine-Levin syndrome. Familial cases and comparison with sporadic cases. Saudi Med J 37(1):21–28. https://doi.org/10.15537/smj.2016.1.12992 CrossRefPubMedPubMedCentral

10.

Arnulf I (2015) Kleine-Levin syndrome. Sleep Med Clin 10(2):151–161. https://doi.org/10.1016/j.jsmc.2015.02.001 CrossRefPubMed

11.

Nebhinani N, Suthar N (2017) Sleeping beauty syndrome: a case report and review of female cases reported from India. Indian J Psychol Med 39(3):357–360. https://doi.org/10.4103/0253-7176.207319 CrossRefPubMedPubMedCentral

12.

Markman RA (1967) Kleine–Levin syndrome: report of a case. Am J Psychiatry 123(8):1025–1026. https://doi.org/10.1176/ajp.123.8.1025 CrossRefPubMed

13.

Masi G, Favilla L, Millepiedi S (2000) The Kleine–Levin syndrome as a neuropsychiatric disorder: a case report. Psychiatry 63(1):93–100. https://doi.org/10.1080/00332747.2000.11024898 CrossRefPubMed

14.

Miller DL (1970) Kleine–Levin syndrome: an atypical case? Psychiatr Q 44(1-4):26–35. https://doi.org/10.1007/BF01562956 CrossRefPubMed

15.

Katz JD, Ropper AH (2002) Familial Kleine-Levin syndrome: two siblings with unusually long hypersomnic spells. Arch Neurol 59(12):1959–1961. https://doi.org/10.1001/archneur.59.12.1959 CrossRefPubMed

16.

Ching KH, Burbeloa PD, Carlson PJ, Drevets WC, Ladarolaa MJ (2010) High levels of anti-GAD65 and anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbance. J Neuroimmunol 222(1–2):87–89. https://doi.org/10.1016/j.jneuroim.2010.02.015 CrossRefPubMedPubMedCentral

17.

Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ, Strand EA, Frye MA, McKeon A (2015) Psychiatric autoimmunity: N-methyl-D-aspartate receptor IgG and beyond. Psychosomatics 56(3):227–241. https://doi.org/10.1016/j.psym.2015.01.003 CrossRefPubMed

18.

Padmos RC, Bekris L, Knijff EM, Tiemeier H, Kupka RW, Cohen D, Nolen WA, Lernmark Å, Drexhage HA (2004) A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry 56(7):476–482. https://doi.org/10.1016/j.biopsych.2004.07.003 CrossRefPubMed

19.

Gadoth N, Kesler A, Vainstein G, Peled R, Lavie P (2001) Clinical and polysomnographic characteristics of 34 patients with Kleine-Levin syndrome. J Sleep Res 10(4):337–341. https://doi.org/10.1046/j.1365-2869.2001.00272.x CrossRefPubMed

20.

Mayer G, Leonhard E, Krieg J, Meier-Ewert K (1998) Endocrinological and polysomnographic findings in Kleine-Levin syndrome: no evidence for hypothalamic and circadian dysfunction. Sleep 21(3):278–284. https://doi.org/10.1093/sleep/21.3.278 CrossRefPubMed

21.

Huang YS, Guilleminault C, Lin KL, Hwang FM, Liu FY, Kung YP (2012) Relationship between Kleine-Levin syndrome and upper respiratory infection in Taiwan. Sleep 35(1):123–129. https://doi.org/10.5665/sleep.1600 CrossRefPubMedPubMedCentral

22.

Luo YW, Yu H, Yuan LH, Zhu GX (2016) A polysomnography study of Kleine-Levin syndrome in a single center. Chin Med J 129(13):1565–1568. https://doi.org/10.4103/0366-6999.184476 CrossRefPubMedPubMedCentral

23.

Reimao R, Shimizu MH (1998) Kleine-Levin syndrome. Clinical course, polysomnography and multiple sleep latency test. Case report Arquivos de Neuro-Psiquiatria 56(3b):650–654. https://doi.org/10.1590/S0004-282X1998000400021 CrossRefPubMed

24.

Huang YS, Lin YH, Guilleminault C (2009) Polysomnography in Kleine-Levin syndrome. Neurology 70:795–801CrossRef

25.

Bourgin P, Zeitzer JM, Mignot E (2008) CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol 7(7):649–662. https://doi.org/10.1016/S1474-4422(08)70140-6 CrossRefPubMed

26.

Liblau RS, Vassalli A, Seifinejad A, Tafti M (2015) Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 14(3):318–328. https://doi.org/10.1016/S1474-4422(14)70218-2 CrossRefPubMed

27.

Cho JW, Kim JH (2016) Recurrent hypersomnia in an 18-year old boy: CSF hypocretin level and MSLT findings. Sleep Med 21:176. https://doi.org/10.1016/j.sleep.2015.07.007 CrossRefPubMed

28.

Dauvilliers Y, Lopez R (2016) Time to find a biomarker in Kleine-Levin syndrome. Sleep Med 21:177. https://doi.org/10.1016/j.sleep.2015.07.013 CrossRefPubMed

29.

Lopez R, Barateau L, Chenini S, Dauvilliers Y (2015) Preliminary results on CSF biomarkers for hypothalamic dysfunction in Kleine-Levin syndrome. Sleep Med 16(1):194–196. https://doi.org/10.1016/j.sleep.2014.07.022 CrossRefPubMed

30.

Podesta C, Ferreras M, Mozzi M, Bassetti C, Dauvilliers Y, Billiard M (2006) Kleine-Levin syndrome in a 14-year-old girl: CSF hypocretin-1 measurements. Sleep Med 7(8):649–651. https://doi.org/10.1016/j.sleep.2006.07.003 CrossRefPubMed

31.

Wang JY, Han F, Dong SX, Li J, An P, Zhang XZ, Chang Y, Zhao L, Zhang XL, Liu YN, Yan H, Li QH, Hu Y, Lv CJ, Gao ZC, Strohl KP (2016) Cerebrospinal fluid orexin A levels and autonomic function in Kleine-Levin syndrome. Sleep 39(4):855–860. https://doi.org/10.5665/sleep.5642 CrossRefPubMedPubMedCentral

32.

Hart EJ (1985) Kleine-Levin syndrome normal CSF monoamines and response to lithium therapy. Neurology 35(9):1395–1396. https://doi.org/10.1212/WNL.35.9.1395-a CrossRefPubMed

33.

Hasegawa Y, Morishita M, Suzumura A (1998) Novel chromosomal abberation in a patient with a unique sleep disorder. J Neurol Neurosurg Psychiatry 64(1):113–116. https://doi.org/10.1136/jnnp.64.1.113 CrossRefPubMedPubMedCentral

34.

Thompson C, Obrecht R, Franey C, Arendt J, Checkley S (1985) Neuroendocrine rhythms in a patient with the Kleine-Levin syndrome. Br J Psychiatry 147(4):440–443. https://doi.org/10.1192/bjp.147.4.440 CrossRefPubMed

35.

Chesson AL Jr, Levine SN, Kong LS, Lee SC (1991) Neuroendocrine evaluation in Kleine-Levin syndrome: evidence of reduced dopaminergic tone during periods of hypersomnolence. Sleep 14:226–232PubMed

36.

Fernández JM, Lara I, Gila L, O’Neill A, Tovar J, Gimeno A (1990) Disturbed hypothalamic-pituitary axis in idiopathic recurring hypersomnia syndrome. Acta Neurol Scand 82(6):361–363. https://doi.org/10.1111/j.1600-0404.1990.tb03317.x CrossRefPubMed

37.

Fukunishi I, Hosokawa K (1989) A female case with the Kleine-Levin syndrome and its physiopathologic aspects. Psychiatry Clin Neurosci 43(1):45–49. https://doi.org/10.1111/j.1440-1819.1989.tb02549.x CrossRef

38.

Gadoth N, Dickerman Z, Bechar M, Laron Z, Lavie P (1987) Episodic hormone secretion during sleep in Kleine-Levin syndrome: evidence for hypothalamic dysfunction. Brain and Development 9(3):309–315. https://doi.org/10.1016/S0387-7604(87)80051-7 CrossRefPubMed

39.

Livrea P, Puca F, Barnaba A, Di Reda L (1977) Abnormal central monoamine metabolism in humans with ‘true hypersomnia’ and ‘sub-wakefulness’. Eur Neurol 15(2):71–76. https://doi.org/10.1159/000114792 CrossRefPubMed

40.

Malhotra S, Das MK, Gupta N, Muralidharan R (1997) A clinical study of Kleine-Levin syndrome with evidence for hypothalamic pituitary axis dysfunction. Biol Psychiatry 42(4):299–301. https://doi.org/10.1016/S0006-3223(97)00252-7 CrossRefPubMed

41.

Maranci JB, Roze E, Benoist JF, Mochel F, Rigal O, Arnulf I (2017) Dopamine and serotonin levels in cerebrospinal fluid during episodes of Kleine-Levin syndrome. Sleep Med 36:184–185. https://doi.org/10.1016/j.sleep.2017.05.001 CrossRefPubMed

42.

Koerber RK, Torkelson R, Haven G, Donaldson J, Cohen SM, Case M (1984) Increased cerebrospinal fluid 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in Kleine-Levin syndrome. Neurology 34(12):1597–1600. https://doi.org/10.1212/WNL.34.12.1597 CrossRefPubMed

43.

Hoexter MQ, Shih MC, Mendes DD, Godeiro-Junior C, Felicio AC, YK F et al (2008) Lower dopamine transporter density in an asymptomatic patient with Kleine-Levin syndrome. Acta Neurol Scand 117(5):370–373. https://doi.org/10.1111/j.1600-0404.2007.00942.x CrossRefPubMed

44.

Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW (2012) Control of sleep and wakefulness. Physiol Rev 92(3):1087–1187. https://doi.org/10.1152/physrev.00032.2011 CrossRefPubMedPubMedCentral

45.

Guilleminault C, Querra-Salva MA, Goldberg MP (1993) Pseudo-hypersomnia and pre-sleep behaviour with bilateral paramedian thalamic lesions. Brain 116(6):1549–1563. https://doi.org/10.1093/brain/116.6.1549 CrossRefPubMed

46.

Haugh RM, Markesbery WR (1983) Hypothalamic astrocytoma. Syndrome of hyperphagia, obesity, and disturbances of behavior and endocrine and autonomic function. Arch Neurol 40(9):560–563. https://doi.org/10.1001/archneur.1983.04050080060011 CrossRefPubMed

47.

Fulton JF, Bailey P (1929) Tumors in the region of the third ventricle: their diagnosis and relation to pathological sleep. J Nerv Ment Dis 69(1):1–25. https://doi.org/10.1097/00005053-192901000-00001 CrossRef

48.

Takayanagi M, Okabe S, Yamamoto K, Komatsu J, Suzuki R, Kitamura T, Ohura T (2017) Kleine–Levin syndrome elicited by encephalopathy with reversible splenial lesion. Pediatrics Int 59(8):929–931. https://doi.org/10.1111/ped.13326 CrossRef

49.

ML L, Liu HC, Chen CH, Sung SM (2000) Kleine–Levin syndrome and psychosis: observation from an unusual case. Neuropsychiatry Neuropsychol Behav Neurol 13:140–142

50.

Kas A, Lavault S, Habert MO, Arnulf I (2014) Feeling unreal: a functional imaging study in 41 patients with Kleine-Levin syndrome. Brain 1377(7):2077–87. https://doi.org/10.1093/brain/awu112

51.

Huang YS, Guilleminault C, Kao PF, Liu FY (2005) SPECT findings in the Kleine-Levin syndrome. Sleep 28(8):955–60, https://doi.org/10.1093/sleep/28.8.955

52.

Vigren P, Engstrom M, Landtblom AM (2014) SPECT in the Kleine-Levin syndrome, a possible diagnostic and prognostic aid? Front Neurol 5:1664–2295CrossRef

53.

Will RG, Young JPR, Thomas DJ (1988) Report of two cases with onset of symptoms precipitated by head trauma. Br J Psychiatry 152(3):410–420. https://doi.org/10.1192/bjp.152.3.410 CrossRefPubMed

54.

Hong SB, Joo EY, Tae WS, Lee J, Han SJ, Lee HW (2006) Episodic diencephalic hypoperfusion in Kleine-Levin syndrome. Sleep 29(8):1091–1093. https://doi.org/10.1093/sleep/29.8.1091 CrossRefPubMed

55.

Landtblom AM, Dige N, Schwerdt K, Säfström P, Granérus G (2002) A case of Kleine–Levin syndrome examined with SPECT and neuropsychological testing. Acta Neurol Scand 105(4):318–321. https://doi.org/10.1034/j.1600-0404.2002.1c162.x CrossRefPubMed

56.

Landtblom AM, Dige N, Schwerdt K, Säfström P, Granérus G (2003) Short-term memory dysfunction in Kleine–Levin syndrome. Acta Neurol Scand 108(5):363–7. https://doi.org/10.1034/j.1600-0404.2003.00171.x

57.

Portilla P, Durand E, Chalvon A, Habert M, Navelet Y, Prigent A, Landrieu P (2002) SPECT-identified hypoperfusion of the left temporomesial structures in a Kleine–Levin syndrome. Rev Neurol (Paris) 158(5 Pt 1):593–595

58.

Engström M, Karlsson T, Landtblom AM (2014) Thalamic activation in the Kleine-Levin syndrome. Sleep 37(2):379–387. https://doi.org/10.5665/sleep.3420 CrossRefPubMedPubMedCentral

59.

Engström M, Hallböök T, Szakacs A, Karlsson T, Landtblom AM (2014) Functional magnetic resonance imaging in narcolepsy and the Kleine–Levin syndrome. Front Neurol 5(105):42PubMedPubMedCentral

60.

Dauvilliers Y, Bayard S, Lopez R, Comte F, Zanca M, Peigneux P (2014) Widespread hypermetabolism in symptomatic and asymptomatic episodes in Kleine-Levin syndrome. PLoS One 9(4):e93813. https://doi.org/10.1371/journal.pone.0093813 CrossRefPubMedPubMedCentral

61.

Lo YC, Chou YH, Yu HY (2012) PET finding in Kleine-Levin syndrome. Sleep Med 13(6):771–772. https://doi.org/10.1016/j.sleep.2012.01.009 CrossRefPubMed

62.

Haba-Rubio J, Prior JO, Guedj E, Tafti M, Heinzer R, Rossetti AO (2012) Kleine-Levin syndrome: functional imaging correlates of hypersomnia and behavioral symptoms. Neurology 79(18):1927–1929. https://doi.org/10.1212/WNL.0b013e318271f85a CrossRefPubMed

63.

Xie H, Guo J, Liu H, Song W (2016) Do the symptoms of Kleine-Levin syndrome correlate with the hypometabolism of the thalamus on FDG PET? Clin Nucl Med 41(3):255–256. https://doi.org/10.1097/RLU.0000000000001043 CrossRefPubMed

64.

Drouet C, Morel O, Verger A, Guedj E, Boulahdour H (2017) FDG brain PET/CT revealing bilateral thalamostriatal activation during a symptomatic episode in a patient with Kleine-Levin syndrome. Clin Nucl Med 42(5):e261–e262. https://doi.org/10.1097/RLU.0000000000001616 CrossRefPubMed

65.

Billings ME, Watson NF, Keogh BP (2011) Dynamic fMRI changes in Kleine-Levin syndrome. Sleep Med 12:531–532CrossRef

66.

Poryazova R, Schnepf B, Boesiger P, Bassetti CL (2007) Magnetic resonance spectroscopy in a patient with Kleine-Levin syndrome. J Neurol 254(10):1445–1446. https://doi.org/10.1007/s00415-007-0531-x CrossRefPubMed

67.

Butter CM, McDonald JA, Snyder DR (1969) Orality, preference behavior, and reinforcement value of nonfood object in monkeys with orbital frontal lesions. Science 164(3885):1306–1307. https://doi.org/10.1126/science.164.3885.1306 CrossRefPubMed

68.

Fontenelle LF, Mendlowicz MV, Marques C, Mattos P, Versiani M (2003) Persistent neuropsychological deficits in the Kleine-Levin syndrome. Acta Neurol Scand 107(4):304–305. https://doi.org/10.1034/j.1600-0404.2003.00090.x CrossRefPubMed

69.

Carpenter S, Yassa R, Ochs R (1982) A pathologic basis for Kleine-Levin syndrome. Arch Neurol 39(1):25–28. https://doi.org/10.1001/archneur.1982.00510130027005 CrossRefPubMed

70.

Fenzi F, Simonati A, Crosato F, Ghersini L, Rizzuto N (1993) Clinical features of Kleine-Levin syndrome with localized encephalitis. Neuropediatrics 24(05):292–295. https://doi.org/10.1055/s-2008-1071559 CrossRefPubMed

71.

Takrani LB, Cronin D (1976) Kleine-Levin syndrome in a female patient. Can Psychiatr Assoc J 21(5):315–318. https://doi.org/10.1177/070674377602100508 CrossRefPubMed

72.

Merriam AE (1986) Kleine-Levin syndrome following acute viral encephalitis. Biol psychiatry (1993) a variant of the Kleine-Levin syndrome precipitated by both Epstein-Barr and varicella-zoster virus infections. Biol Psychiatry 33:388–390

73.

Kornum BR, Rico T, Lin L, Huang YS, Arnulf I, Jennum P, Mignot E (2015) Serum cytokine levels in Kleine-Levin syndrome. Sleep Med 16(8):961–965. https://doi.org/10.1016/j.sleep.2015.02.540 CrossRefPubMed

74.

Silber MH (2016) Autoimmune sleep disorders handbook of clinical neurology, Vol. 133 (3rd series) pp 317-25 Autoimmune Neurology S.J. Pittock and A. Vincent, Editors Elsevier B.V

75.

Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC (1995) Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3(4):407–415. https://doi.org/10.1016/1074-7613(95)90170-1 CrossRefPubMed

76.

Gregersen PK, Olsson LM (2009) Recent advances in the genetics of autoimmune disease. Ann Rev Immunol 27(1):363–91, https://doi.org/10.1146/annurev.immunol.021908.132653

77.

Manni R, Martinetti M, Ratti MT, Tartara A (1993) Electrophysiological and immunogenetic findings in recurrent monosymptomatic-type hypersomnia: a study of two unrelated Italian cases. Acta Neurol Scand 88(4):293–295. https://doi.org/10.1111/j.1600-0404.1993.tb04239.x CrossRefPubMed

78.

BaHammam AS, GadElRab MO, Owais SM, Alswat K, Hamam KD (2008) Clinical characteristics and HLA typing of a family with Kleine-Levin syndrome. Sleep Med 9(5):575–578. https://doi.org/10.1016/j.sleep.2007.06.015 CrossRefPubMed

79.

Rocamora R, Gil-Nagel A, Franch O, Vela-Bueno A (2010) Familial recurrent hypersomnia: two siblings with Kleine-Levin syndrome and menstrual-related hypersomnia. J Child Neurol 25(11):1408–1410. https://doi.org/10.1177/0883073810366599 CrossRefPubMed

80.

Ueno T, Fukuhara A, Ikegami A, Ohishi F, Kume K (2012) Monozygotic twins concordant for Kleine-Levin syndrome. BMC Neurol 12(1):31. https://doi.org/10.1186/1471-2377-12-31 CrossRefPubMedPubMedCentral

81.

Visscher F, van der Horst AR, Smit LM (1990) HLA-DR antigens in Kleine-Levin syndrome. Ann Neurol 28(2):195. https://doi.org/10.1002/ana.410280216 CrossRefPubMed

82.

Lavault S, Golmard JL, Groos E, Brion A, Dauvilliers Y, Lecendreux M, Franco P, Arnulf I (2015) Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol 77(3):529–540. https://doi.org/10.1002/ana.24350 CrossRefPubMed

83.

Nguyen QT, Groos E, Leclair-Visonneau L, Monaca-Charley C, Rico T, Farber N et al (2016) Familial Kleine Levin syndrome: a specific entity? Sleep 39(8):1535–1542. https://doi.org/10.5665/sleep.6014 CrossRefPubMedPubMedCentral

84.

Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12(1):991–1045. https://doi.org/10.1146/annurev.iy.12.040194.005015

85.

Bianchi ME (2007) DAMPs PAM: Ps and alarmins: all we need to know about danger. J Leukoc Biol 81(1):1–5. https://doi.org/10.1189/jlb.0306164 CrossRefPubMed

86.

Hirsiger S, Simmen H-P, Werner CML, Wanner GA, Rittirsch D (2012) Danger signals activating the immune response after trauma. Mediat Inflamm 2012:1–10. https://doi.org/10.1155/2012/315941 CrossRef

87.

Cranfield A, Mathavakkannan S (2015) Goodpasture’s disease following extracorporeal shock wave lithotripsy: a case report & literature review. Clin Case Rep 3(3):160–164. https://doi.org/10.1002/ccr3.190 CrossRefPubMed

88.

Adenuga O, Attarian H (2014) Treatment of disorders of hypersomnolence. Curr Treat Options Neurol 16(9):302. https://doi.org/10.1007/s11940-014-0302-9 CrossRefPubMed

89.

Itokawa K, Fukui M, Ninomiya M, Yamamoto T, Imabayashi E, Tamura N, Matsuda H, Araki N (2009) Gabapentin for Kleine-Levin syndrome. Internal Med 48(13):1183–1185. https://doi.org/10.2169/internalmedicine.48.2204 CrossRef

90.

Perin BV, Rodrigues I, Giasson FT, Balen M, Posenato N, Forcelini CM (2015) Recurrent hypersomnia: report of medication-responsive cases. Sleep Sci 8(2):100–102. https://doi.org/10.1016/j.slsci.2015.06.003 CrossRefPubMedPubMedCentral

91.

Mukaddes NM, Kora ME, Bilge S (1999) Carbamazepine for Kleine-Levin syndrome. J Am Acad Child Adolesc Psychiatry 38(7):791–792. https://doi.org/10.1097/00004583-199907000-00001 CrossRefPubMed

92.

Surges R, Walker MC (2009) A case of late-onset Kleine-Levin syndrome responding to lamotrigine. Sleep Med 10(3):394. https://doi.org/10.1016/j.sleep.2008.03.001 CrossRefPubMed

93.

Adlakha A, Chokroverty S (2009) An adult onset patient with Kleine-Levin syndrome responding to valproate. Sleep Med 10(3):391–393. https://doi.org/10.1016/j.sleep.2008.07.006 CrossRefPubMed

94.

Crumley FE (1997) Valproic acid for Kleine-Levin syndrome. J Am Acad Child Adolesc Psychiatry 36(7):868–869. https://doi.org/10.1097/00004583-199707000-00005 CrossRefPubMed

95.

Das S, Gupta R, Dhyani M, Raghuvanshi S (2014) Kleine-Levin syndrome: a case report and review of literature. Pediatr Neurol 50(4):411–416. https://doi.org/10.1016/j.pediatrneurol.2014.01.003 CrossRefPubMed

96.

Goldberg MA (1983) The treatment of Kleine-Levin syndrome with lithium. Canadian J Psychiatry 28(6):491–493CrossRef

97.

Mendhekar DN, Jiloha RC, Gupta D (2001) Kleine-levin syndrome: a report of two cases. Indian J Psychiatry 43(3):276–278PubMedPubMedCentral

98.

Muratori F, Bertini N, Masi G (2002) Efficacy of lithium treatment in Kleine-Levin syndrome. European Psychiatry 17(4):232–233. https://doi.org/10.1016/S0924-9338(02)00661-2 CrossRefPubMed

99.

Poppe M, Friebel D, Reuner U, Todt H, Koch R, Heubner G (2003) The Kleine-Levin syndrome—effects of treatment with lithium. Neuropediatrics 34(3):113–119. https://doi.org/10.1055/s-2003-41273 CrossRefPubMed

100.

Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ (2006) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol Psychiatry 59(5):401–407. https://doi.org/10.1016/j.biopsych.2005.07.024 CrossRefPubMed

101.

Lee HJ, Ertley RN, Rapoport SI, Bazinet RP, Rao JS (2008) Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex. Neurochem Res 33(5):861–866. https://doi.org/10.1007/s11064-007-9526-3 CrossRefPubMed

102.

Chang MC, Contreras MA, Rosenberger TA, Rintala JJ, Bell JM, Rapoport SI (2001) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J Neurochem 77(3):796–803. https://doi.org/10.1046/j.1471-4159.2001.00311.x CrossRefPubMed

103.

Rapoport SI, Bosetti F (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch Gen Psychiatry 59(7):592–596. https://doi.org/10.1001/archpsyc.59.7.592 CrossRefPubMed

104.

Nassar A, Azab AN (2014) Effects of lithium on inflammation. ACS Chem Neurosci 5(6):451–458. https://doi.org/10.1021/cn500038f CrossRefPubMedPubMedCentral

105.

Leu-Semenescu S, Le Corvec T, Groos E, Lavault S, Golmard JL, Arnulf I (2015) Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients. Neurology 85(19):1655–1662. https://doi.org/10.1212/WNL.0000000000002104 CrossRefPubMed

106.

Parmar A, Yadav P, Patra BN, Sagar R (2017) Successful long-term management of a child with Kleine-Levin syndrome with low-dose lithium. Indian J Psychol Med 39(4):531–533. https://doi.org/10.4103/0253-7176.211741 CrossRefPubMedPubMedCentral

107.

de Oliveira MM, Conti C, Prado GF (2016) Pharmacological treatment for Kleine-Levin syndrome. Cochrane Database Syst Rev (5):Cd006685

108.

Al Suwayri SM, BaHammam AS (2017) The “known unknowns” of Kleine-Levin syndrome: a review and future prospects. Sleep Med Clin 12(3):345–358. https://doi.org/10.1016/j.jsmc.2017.03.012 CrossRefPubMed

109.

Dauvilliers Y, Abril B, Mas E, Michel F, Tafti M (2009) Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology 73(16):1333–1334. https://doi.org/10.1212/WNL.0b013e3181bd1344 CrossRefPubMed

Title: Kleine-Levin syndrome: clues to aetiology
Authors: Saad Mohammed AlShareef
Richard Mark Smith
Ahmed Salem BaHammam
Publication date: 01-09-2018
Publisher: Springer International Publishing
Published in: Sleep and Breathing / Issue 3/2018
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-017-1617-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Kleine-Levin syndrome: clues to aetiology

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2018

Complex sleep apnea after full-night and split-night polysomnography: the Greek experience

Comorbid obstructive sleep apnea and increased risk for sickle cell disease morbidity

Abstracts of the 9th International Sleep Surgical Society Meeting, 5–7th April 2018, Munich, Germany

Prevalence of obstructive sleep apnoea in REM behaviour disorder: response to continuous positive airway pressure therapy

Reply to “Obstructive sleep apnea patients without hypertension or diabetes and subsequent incidence of chronic kidney disease” by Kawada (letter to the editor)

The effect of unilateral forced nostril breathing on sleep in healthy right-handed men: a preliminary report

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page